3,304 UnitedHealth Group Incorporated $UNH Shares Bought by Fulcrum Asset Management LLP

Fulcrum Asset Management LLP raised its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 77.3% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 7,578 shares of the healthcare conglomerate’s stock after buying an additional 3,304 shares during the period. Fulcrum Asset Management LLP’s holdings in UnitedHealth Group were worth $2,841,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. Corient Private Wealth LP bought a new position in UnitedHealth Group in the second quarter worth approximately $245,516,000. Legal & General Group Plc bought a new stake in UnitedHealth Group during the 2nd quarter valued at $2,444,928,000. Jupiter Topco LLC purchased a new stake in shares of UnitedHealth Group in the 2nd quarter worth $2,019,844,000. BlackRock Inc. lifted its holdings in shares of UnitedHealth Group by 4.6% in the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock worth $31,946,594,000 after buying an additional 3,395,530 shares during the period. Finally, Canada Pension Plan Investment Board bought a new position in shares of UnitedHealth Group during the 2nd quarter worth $971,757,000. 87.86% of the stock is currently owned by institutional investors.

Insider Activity

In other news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at $5,977,920. This represents a 7.09% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.19% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

UNH has been the subject of several recent research reports. Raymond James Financial restated an “outperform” rating and issued a $450.00 price objective on shares of UnitedHealth Group in a report on Thursday, October 15th. Bank of America reiterated a “buy” rating and set a $450.00 target price on shares of UnitedHealth Group in a report on Monday, July 20th. Stephens set a $500.00 target price on shares of UnitedHealth Group in a research report on Friday, October 16th. Wall Street Zen upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Finally, Robert W. Baird lowered their price target on shares of UnitedHealth Group from $453.00 to $427.00 and set a “neutral” rating for the company in a research report on Wednesday, October 14th. Twenty equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $463.93.

Get Our Latest Analysis on UNH

UnitedHealth Group Trading Up 1.8%

UNH opened at $404.88 on Wednesday. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.66. The firm has a market cap of $362.78 billion, a price-to-earnings ratio of 23.12, a PEG ratio of 1.44 and a beta of 0.51. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62. The stock has a fifty day moving average price of $390.98 and a 200-day moving average price of $364.53.

UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating the consensus estimate of $4.14 by $0.55. The firm had revenue of $112.72 billion during the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The business’s revenue for the quarter was down .4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be issued a $2.32 dividend. The ex-dividend date of this dividend is Monday, December 7th. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group’s payout ratio is presently 53.00%.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.